In a strategic move to diversify its portfolio and strengthen its European footprint, UK-based The Tofoo Co., backed by private equity, has acquired German seitan specialist Topas, owner of the Wheaty brand.
A new mandatory scheme requires all UK fuel stations to report price changes within 30 minutes, with data fed to comparison apps. The government-backed initiative aims to boost competition and save households an estimated £40 annually.
Private equity firm Exponent has halted the auction of UK accounting group Xeinadin after potential buyers refused to meet its £1bn valuation, signaling potential headwinds for deal-making in the professional services sector.
Despite underperforming the broader market since August 2025, insurance marketplace platform MediaAlpha (MAX) exhibits robust fundamentals—including sustained sales growth, expanding cash flow margins, and rising returns on capital—that could signal significant upside potential for patient investors.
Jacobs Solutions lands pivotal roles in California wastewater upgrades and UK nuclear project, reinforcing its position in sustainable infrastructure despite shares trading below analyst targets.
UK Labour leader Keir Starmer urges sustained engagement with Beijing, countering Donald Trump's call for Western disengagement and highlighting deepening geopolitical divides.
Amidst recent market volatility driven by regional tensions, a closer look reveals companies with strong fundamentals demonstrating remarkable resilience and growth potential. We examine three such firms that are navigating the uncertainty and positioning themselves for the future.
The UK's economic recovery faces a significant drag from recently implemented fiscal tightening, with growth forecasts remaining subdued for the coming year, according to a leading economic forecaster.
Glaukos Corporation secures a significant FDA nod allowing repeated administration of its sustained-release iDose TR implant, broadening treatment options for patients with glaucoma and potentially reshaping long-term care paradigms.
Amidst the allure of high-growth tech narratives, Acsion (JSE:ACS) presents a case for steady, profitable growth. With strong insider alignment and improving margins, does this property-focused stock warrant a closer look from discerning investors?
As voters from Japan to Brazil head to the polls in a packed electoral calendar, investors brace for potential market volatility. The outcomes could redefine fiscal policies, international alliances, and economic trajectories in a world already navigating U.S. monetary uncertainty and geopolitical strife.
Asian markets opened cautiously Monday as a historic metals sell-off reverberated across asset classes. Bitcoin slipped toward $75,000, while regional equities mostly fell. Investors brace for a critical week packed with corporate earnings, central bank decisions, and key economic data.
Voya Financial is set to report fourth-quarter earnings after the bell Tuesday. Investors will watch to see if the financial services firm can maintain its impressive track record of surpassing revenue estimates, even as broader market headwinds pressure the custody banking sector.
Glaukos Corporation's iDose TR glaucoma therapy receives a key FDA labeling update, permitting repeat administration. While the news bolsters the company's growth narrative, analysts are divided on whether its current stock price already reflects future potential amid rich valuation metrics.
Hyundai Motor has allowed its option to repurchase its former St. Petersburg factory to lapse, marking a decisive step back from the Russian market it once dominated, as the ongoing conflict and sanctions reshape the automotive landscape.
Realtor.com ranks the Florida Keys among the nation's top luxury markets, where strict development limits and finite land create a high-stakes arena for elite buyers seeking a unique legacy, not just a second home.
While market darlings come and go, a select group of companies achieves sustained outperformance through a powerful trifecta: rising sales, expanding profitability, and efficient capital use. We examine three such names that have delivered triple-digit returns over the past five years.
Guggenheim analyst Subbu Nambi raises her price target on Bruker Corporation (BRKR) from $53 to $58, maintaining a Buy rating and projecting nearly 25% upside, as the life sciences tools sector shows resilience.
Nikolay Storonsky, the billionaire CEO of fintech giant Revolut, has officially corrected corporate records to reaffirm his UK residency, following a brief filing that listed him in the UAE—a move that had sent shockwaves through regulators and political circles.
A UK tribunal has allowed a massive lawsuit accusing Valve of anti-competitive practices to proceed, drawing vocal support from Epic Games CEO Tim Sweeney, who calls Steam the last major platform clinging to restrictive payment rules.
